These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 636101)

  • 1. [Platelet-inhibiting drugs].
    Jobin F
    Union Med Can; 1978 Feb; 107(2):163-6,171-7. PubMed ID: 636101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
    Hansen MS; Birgens HS
    Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological properties of drug inhibiting platelet aggregation.
    de Gaetano G
    Acta Clin Belg; 1975; 30(3):184-9. PubMed ID: 1231456
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
    Weiss HJ
    Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G; Cerletti C; Bertelè V
    Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of aggregation inhibitors].
    Weber E
    Med Welt; 1976 Jun; 27(25):1217-21. PubMed ID: 933806
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology of anti-aggregating substances.
    Vermylen J
    Acta Clin Belg; 1975; 30(3):204-9. PubMed ID: 1231459
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
    Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
    Rhyner K; Stenger M; Block LH
    Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1211-4. PubMed ID: 6430669
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
    Birgens HS; Hansen MS
    Ugeskr Laeger; 1980 Jan; 142(5):306-9. PubMed ID: 6986701
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of immune complex induced human platelet aggregation and release in plasma.
    Clark WF; Tevaarwerk GJ; Moriarity TA; Reid BD
    Thromb Res; 1982 Dec; 28(5):681-8. PubMed ID: 7167877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between inhibitory effect of anti-platelet drugs on platelet aggregation and clinical value (author's transl)].
    Yasunaga K; Kanzaki M
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):552-3. PubMed ID: 495017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.